Literature DB >> 10743912

Comparison of the reinforcing and anxiogenic effects of intravenous cocaine and cocaethylene.

Mary A Raven1, Brian D Necessary, Deborah A Danluck, Aaron Ettenberg.   

Abstract

People report that ethanol improves the experience produced by cocaine. This effect may be attributable to cocaethylene (CE), a cocaine metabolite formed only in the presence of ethanol. To test this, rats were trained to run an alley for a single intravenous dose of either cocaine (0.5-2.0 mg/kg) or an equimolar dose of CE (0.75-2.88 mg/kg). The rats' start latency and running speed measured the reinforcing effects of the drugs and the number of times rats approached but failed to enter the goal box (i.e., approach-avoidance retreats) indexed anxiety. Rats reinforced with CE had shorter start latencies and faster running speeds and exhibited fewer "retreats" than cocaine-reinforced rats. These results suggest that CE is more reinforcing and less anxiogenic than cocaine and hence may account for the combined effects of cocaine and ethanol in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10743912     DOI: 10.1037/1064-1297.8.1.117

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  28 in total

1.  Weakening of negative relative to positive associations with cocaine-paired cues contributes to cue-induced responding after drug removal.

Authors:  Zu-In Su; Gleb Kichaev; Jennifer Wenzel; Osnat Ben-Shahar; Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2011-10-08       Impact factor: 3.533

2.  Kindling modifies morphine, cocaine and ethanol place preference.

Authors:  Axel Becker; Marco Schmitz; Gisela Grecksch
Journal:  Exp Brain Res       Date:  2005-08-11       Impact factor: 1.972

3.  On the positive and negative affective responses to cocaine and their relation to drug self-administration in rats.

Authors:  Aaron Ettenberg; Vira Fomenko; Konstantin Kaganovsky; Kerisa Shelton; Jennifer M Wenzel
Journal:  Psychopharmacology (Berl)       Date:  2015-02-07       Impact factor: 4.530

4.  Desire to Drink Alcohol is Enhanced with High Caffeine Energy Drink Mixers.

Authors:  Cecile A Marczinski; Mark T Fillmore; Amy L Stamates; Sarah F Maloney
Journal:  Alcohol Clin Exp Res       Date:  2016-07-15       Impact factor: 3.455

5.  Effects of lidocaine-induced inactivation of the bed nucleus of the stria terminalis, the central or the basolateral nucleus of the amygdala on the opponent-process actions of self-administered cocaine in rats.

Authors:  Jennifer M Wenzel; Stephanie A Waldroup; Zachary M Haber; Zu-In Su; Osnat Ben-Shahar; Aaron Ettenberg
Journal:  Psychopharmacology (Berl)       Date:  2011-04-13       Impact factor: 4.530

6.  Pharmacological modulation of lateral habenular dopamine D2 receptors alters the anxiogenic response to cocaine in a runway model of drug self-administration.

Authors:  Kerisa Shelton; Kelsie Bogyo; Tinisha Schick; Aaron Ettenberg
Journal:  Behav Brain Res       Date:  2016-05-04       Impact factor: 3.332

7.  Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration.

Authors:  Aaron Ettenberg; Rick E Bernardi
Journal:  Pharmacol Biochem Behav       Date:  2006-10-24       Impact factor: 3.533

8.  The effects of medial prefrontal cortex infusions of cocaine in a runway model of drug self-administration: evidence of reinforcing but not anxiogenic actions.

Authors:  Daniel Guzman; Justin M Moscarello; Aaron Ettenberg
Journal:  Eur J Pharmacol       Date:  2009-01-10       Impact factor: 4.432

9.  Ethanol consumption reduces the adverse consequences of self-administered intravenous cocaine in rats.

Authors:  L A Knackstedt; A Ettenberg
Journal:  Psychopharmacology (Berl)       Date:  2004-08-25       Impact factor: 4.530

10.  Heightened drug-seeking motivation following extended daily access to self-administered cocaine.

Authors:  Osnat Ben-Shahar; Eric J Posthumus; Stephanie A Waldroup; Aaron Ettenberg
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-01-11       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.